| Current Price | $142.23 | Mkt Cap | $4.7B |
|---|---|---|---|
| Open | $137.73 | P/E Ratio | 24.94 |
| Prev. Close | $139.53 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $137.09 - $142.67 | Volume | 172,954 |
| 52-Wk Range | $126.95 - $231.00 | Avg. Daily Vol. | 281,034 |
| Current Price | $142.23 | Mkt Cap | $4.7B |
|---|---|---|---|
| Open | $137.73 | P/E Ratio | 24.94 |
| Prev. Close | $139.53 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $137.09 - $142.67 | Volume | 172,954 |
| 52-Wk Range | $126.95 - $231.00 | Avg. Daily Vol. | 281,034 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about MEDP.
Recs
NapaCabernet
(< 20)
Submitted: 12/22/2021 3:19:15 PM :
Start Price:
$220.84
NASDAQ:MEDP Score:
-22.46
BS Pick and buy
Recs
TMFjimhalley
(23.61)
Submitted: 5/17/2021 10:14:05 PM :
Start Price:
$163.28
NASDAQ:MEDP Score:
-10.42
Clinical research organizations such as Medpace are seeing increased revenue because their expertise is particularly helpful to emerging pharmaceutical companies. The company has increasedits revenue 145% over the past three years and doesn't seem to be slowing down.
Recs
ProfitJim
(< 20)
Submitted: 5/5/2021 2:10:56 PM :
Start Price:
$164.03
NASDAQ:MEDP Score:
-10.91
Good growth. Contract research org. Relatively low mkt cap in Life Sciences with large opp to grow. In the small and mid sized biopharma segment. Accelerating Revenue and Profitability over the past 3 years, along with strong EPS growth (over 50% CAGR for the past 3 years).
Find the members with the highest scoring picks in MEDP.
dorog (< 20) Score: +120.99
The Score Leader is the player with the highest score across all their picks in MEDP.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| WasGibt | 21.61 | 11/1/2018 |
|
5Y | $52.01 | +172.06% | +48.98% | +123.09 | 0 Comment | |
| PaulNy | 95.68 | 5/24/2019 |
|
5Y | $57.20 | +147.38% | +42.73% | +104.64 | 0 Comment | |
| ssinvplace | < 20 | 2/19/2019 |
|
3M | $70.55 | +100.57% | +46.00% | +54.57 | 0 Comment | |
| sandvig | 95.61 | 1/10/2020 |
|
5Y | $84.18 | +68.09% | +23.28% | +44.81 | 0 Comment | |
| TDogg | < 20 | 5/4/2020 |
|
5Y | $76.02 | +86.13% | +43.84% | +42.28 | 0 Comment | |
| Plasmidologist | 27.09 | 8/23/2019 |
|
5Y | $79.70 | +77.53% | +41.30% | +36.23 | 0 Comment | |
| sublimeinvestor | 27.03 | 8/23/2019 |
|
5Y | $79.70 | +77.53% | +41.30% | +36.23 | 0 Comment | |
| L8starter | 50.11 | 4/29/2020 |
|
5Y | $82.08 | +72.39% | +38.05% | +34.34 | 0 Comment | |
| DaytradingStars | 22.76 | 6/9/2020 |
|
5Y | $92.38 | +53.17% | +26.18% | +27.00 | 0 Comment | |
| snowman12345 | 40.42 | 4/27/2020 |
|
5Y | $85.12 | +66.24% | +41.55% | +24.69 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
